Izotropic Engages Dr. Craig Abbey for Breast CT Reader Study Design
Vancouver, British Columbia--(Newsfile Corp. - July 8, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce that it has engaged Dr. Craig Abbey, Ph.D., to develop and present proposed reader study designs to the FDA during the Company's pre-submission meeting for approval of its Breast CT Imaging System. Dr. Abbey has a Ph.D. in Applied Mathematics and currently holds a professional Researcher position at the University of...
2020-07-08 3:01 AM EDT
Izotropic Corporation Appoints Executive Vice President of Commercial Operations
Vancouver, British Columbia--(Newsfile Corp. - July 6, 2020) - Izotropic Corporation (CSE: IZO) (OTC PINK: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce the appointment of John McGraw, Ph.D., as Executive Vice President of Commercial Operations. Dr. McGraw brings over 20 years of technology and business development experience spanning several medical device and healthcare-related market segments and has created and implemented successful strategies for the...
2020-07-06 3:01 AM EDT
Izotropic Begins FDA Approval Process
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce it has engaged company advisor and FDA Consultant, Anita Nosratieh Ph.D., to develop and manage the Company's application for FDA medical device approval of its dedicated Breast CT Imaging System. The first stage towards FDA approval is focused on developing a detailed pre-submission strategy and application, which...
2020-05-25 3:01 AM EDT
FDA Consultant Joins Izotropic Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - May 20, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce that Anita Nosratieh Ph.D., as a new member of the Company's Advisory Board. Nosratieh began her career as a lead reviewer at the Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) where she worked with companies seeking approval of breast cancer screening and diagnostic devices. As...
2020-05-20 3:01 AM EDT
Izotropic Engages StarFish Medical for Design and Development of Commercial Breast CT Model
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce it has engaged StarFish Medical, Canada's largest medical device design, development and contract manufacturing company, to complete the final design and development of the Company's commercial breast CT model. StarFish Medical Founder and CEO Scott Phillips commented on the collaboration: "We have worked with...
2020-05-13 3:01 AM EDT
Izotropic Announces Issuance of Patent to Use Breast CT for Robotic Guided Biopsy
Vancouver, British Columbia--(Newsfile Corp. - May 7, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce the United States Patent and Trademark Office has issued U. S. Patent No. 11/913494, entitled "Biopsy Systems For Breast Computed Tomography". A Notice of Allowance was announced for this patent in February of this year. The patent covers the use of Izotropic Corporation's dedicated Breast CT Imaging System for...
2020-05-07 3:00 AM EDT
Izotropic Announces Addition of George Burkett, M.Eng., to Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to announce the addition of Mr. George Burkett, M.Eng., to the Advisory Board. Mr. Burkett graduated with a Master's Degree in Mechanical and Aeronautical Engineering in 2002 and has spent the last 15 years working at UC Davis Medical Center in Sacramento, CA (UC Davis). He is the primary engineer responsible for developing...
2020-04-22 9:00 AM EDT
Izotropic Announces Issuance of Patent to Measure Breast Density with Breast CT Technology
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") Izotropic Corporation is pleased to announce the United States Patent and Trademark Office has issued U. S. Patent No. 10,548,549, entitled "Measuring Breast Density Using Breast Computed Tomography" for a 20-year term, expiring in 2037. This patent covers the use of the Company's Breast CT Imaging System to measure breast density....
2020-04-15 9:00 AM EDT
Izotropic Provides Update on Globally Licensed Breast CT Technology
Toronto, Ontario--(Newsfile Corp. - February 27, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") is pleased to provide an update regarding early stage commercialization action plans to bring its globally licensed breast CT technology to market. The first initiative underway includes collaborative design and engineering of the commercial model and preparation for manufacturing and submission for FDA approval and European CE Mark. The second...
2020-02-27 7:30 AM EST
Izotropic Successfully Extends Exclusive Global License Agreement for Innovative Breast CT Technology Until 2027
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") The Company is pleased to announce that it has extended the terms of its exclusive global License Agreement with The Regents of the University of California. The amendments under the revised exclusive global License Agreement relate to the formal Commercialization Plan of breast CT technology developed at UC Davis Medical Center in...
2020-02-26 7:30 AM EST
Izotropic Receives Notice of Allowance for Measuring Breast Density from US Patent Office
Vancouver, British Columbia--(Newsfile Corp. - February 19, 2020) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") Izotropic Corporation is pleased to announce that a notice of allowance has been received from the United States Patent and Trademark office ("USPTO") for the patent application No. 15/669829, entitled "Measuring Breast Density Using Breast Computed Tomography." This notice of allowance is the final step before the patent is formally...
2020-02-19 7:30 AM EST
Izotropic Corporation Completes Initial Public Offering
Vancouver, British Columbia--(Newsfile Corp. - May 31, 2018) - Izotropic Corporation (CSE: IZO) ("Izotropic" or the "Company") is pleased to announce that it has successfully completed its initial public offering (the "IPO") of 2,000,000 common shares in the capital of the Company (each, a "Share") at a price of $0.10 per Share for gross proceeds of $200,000 (the "Proceeds"). Chippingham Financial Group Limited acted as agent (the "Agent") for the IPO. The Company paid the Agent a cash...
2018-05-31 5:31 PM EDT